<DOC>
	<DOC>NCT00276042</DOC>
	<brief_summary>The study will be conducted in infants and children with acute otitis media, 6 months to less than 7 years old, in Costa Rica and Israel. The primary objective of this trial will be to describe bacteriologic efficacy in those with initial culture positive specimens with different dosages of faropenem</brief_summary>
	<brief_title>A Trial to Evaluate Faropenem Medoxomil in the Treatment of Acute Otitis Media</brief_title>
	<detailed_description>The study will be conducted in infants and children with acute otitis media, 6 months to &lt;7 years old, in Costa Rica and Israel. Faropenem is to be used as therapy for both simple and complicated AOM.</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>beta-Lactams</mesh_term>
	<criteria>Acute Otis Media Any antibiotic for more than 24 hours (unless a treatment failure) within 7 days prior to enrollment</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>AOM</keyword>
</DOC>